BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26095833)

  • 1. Hepatotoxicity mechanisms of isoniazid: A mini-review.
    Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
    J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CYP3A in isoniazid metabolism in vivo.
    Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
    Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes.
    Lee KK; Fujimoto K; Zhang C; Schwall CT; Alder NN; Pinkert CA; Krueger W; Rasmussen T; Boelsterli UA
    Free Radic Biol Med; 2013 Dec; 65():584-594. PubMed ID: 23911619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».
    Souayed N; Chennoufi M; Boughattas F; Haouas Z; Maaroufi K; Miled A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
    Chronobiol Int; 2015; 32(9):1201-10. PubMed ID: 26479844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor.
    Sarich TC; Adams SP; Petricca G; Wright JM
    J Pharmacol Exp Ther; 1999 May; 289(2):695-702. PubMed ID: 10215642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats.
    Yue J; Peng RX; Yang J; Kong R; Liu J
    Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
    Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway.
    Jia ZL; Cen J; Wang JB; Zhang F; Xia Q; Wang X; Chen XQ; Wang RC; Hsiao CD; Liu KC; Zhang Y
    Chemosphere; 2019 Jul; 227():541-550. PubMed ID: 31004821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of isoniazid-induced hepatotoxicity.
    Perwitasari DA; Atthobari J; Wilffert B
    Drug Metab Rev; 2015 May; 47(2):222-8. PubMed ID: 26095714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
    Boelsterli UA; Lee KK
    J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.
    Mach J; Huizer-Pajkos A; Mitchell SJ; McKenzie C; Phillips L; Kane A; Jones B; de Cabo R; Cogger V; Le Couteur DG; Hilmer SN
    Fundam Clin Pharmacol; 2016 Feb; 30(1):23-34. PubMed ID: 26454000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicoproteomic Profiling of
    Brewer CT; Kodali K; Wu J; Shaw TI; Peng J; Chen T
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage.
    Goh ZH; Tee JK; Ho HK
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.
    Guo YX; Xu XF; Zhang QZ; Li C; Deng Y; Jiang P; He LY; Peng WX
    Toxicol Mech Methods; 2015; 25(5):382-7. PubMed ID: 25886055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria.
    Ahadpour M; Eskandari MR; Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Jafarian I; Naserzadeh P; Hosseini MJ
    Drug Chem Toxicol; 2016; 39(2):224-32. PubMed ID: 26461142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
    Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN
    Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.
    Zhou L; Song Y; Zhao J; Qin H; Zhang G; Zhou Y; Wu X
    Pharm Biol; 2016; 54(6):931-7. PubMed ID: 26987268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
    Vuilleumier N; Rossier MF; Chiappe A; Degoumois F; Dayer P; Mermillod B; Nicod L; Desmeules J; Hochstrasser D
    Eur J Clin Pharmacol; 2006 Jun; 62(6):423-9. PubMed ID: 16770646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.